Suppression of anti-cancer immunity by regulatory T cells: back to the future.
about
Interaction between natural killer cells and regulatory T cells: perspectives for immunotherapyThe role of the immune system in non-small cell lung carcinoma and potential for therapeutic interventionHarnessing the Power of Onco-Immunotherapy with Checkpoint InhibitorsThe role of regulatory T cells in cancer.Early expression of stem cell-associated genes within the CD8 compartment after treatment with a tumor vaccineTumor emergence is sensed by self-specific CD44hi memory Tregs that create a dominant tolerogenic environment for tumors in mice.Scutellaria barbata D. Don extract inhibits the tumor growth through down-regulating of Treg cells and manipulating Th1/Th17 immune response in hepatoma H22-bearing mice.Construction and Production of Foxp3-Fc (IgG) DNA Vaccine/Fusion ProteinHierarchical and selective roles of galectins in hepatocarcinogenesis, liver fibrosis and inflammation of hepatocellular carcinoma.Mechanisms of immune response regulation in lung cancer.Neutrophils: important contributors to tumor progression and metastasis.Expanding Diversity and Common Goal of Regulatory T and B Cells. II: In Allergy, Malignancy, and Transplantation.Murine rhabdomyosarcoma is immunogenic and responsive to T-cell-based immunotherapy.Enhancement of lytic activity of leukemic cells by CD8+ cytotoxic T lymphocytes generated against a WT1 peptide analogue.Induction of immunity to neuroblastoma early after syngeneic hematopoietic stem cell transplantation using a novel mouse tumor vaccine.Contribution of galectin-1, a glycan-binding protein, to gastrointestinal tumor progression.Immature myeloid cells and tolerogenic cytokine profile in lung adenocarcinoma metastatic lymph nodes assessed by endobronchial ultrasound.Prognostic value of circulating regulatory T cell subsets in untreated non-small cell lung cancer patients.Lymphocyte subsets in pediatric migraine.Long-term effects of idiotype vaccination on the specific T-cell response in peripheral blood and bone marrow of multiple myeloma patients.Natural killer cells unleashed: Checkpoint receptor blockade and BiKE/TriKE utilization in NK-mediated anti-tumor immunotherapy.
P2860
Q27008625-E0B137EC-BA11-40CF-BFEE-B467B6199103Q27024781-389ABAB8-A381-480F-AAE2-8C9889D5118DQ28086999-3DB85D02-8FB9-4165-B15F-52507CC6103BQ33631986-1189F6A1-20AC-48C7-8C95-C9208B2E9E46Q34110774-A1033C39-D2A3-4854-B822-B0BBB9F34434Q34610483-A1133D4B-0171-4DCE-8030-060482B07C27Q36249201-86176E07-34AD-44B9-8ADE-226CF7DD638AQ36828834-2AFE6916-01FA-41A6-A800-4214C3104297Q38174863-8EBE3DF3-DAC6-49DF-9CEA-FA0F51968E66Q38390097-3C3B44F9-C916-4BEE-9023-2B856DA7FBB7Q38585102-7E286EB8-F629-47E5-BC51-C526001E4F6DQ39282520-B9D3C153-E5C4-456A-91EF-8EF98413BDCDQ39564978-5EA1FCD7-F9CC-47E8-8B20-A3337605F9CBQ39886839-FD9678B5-7CFE-420F-B3BD-6538BA4249AEQ40167750-CCA1981C-468F-4E42-B0C2-D47201BC8FD5Q41334598-F83AD738-4A03-4703-802E-F658F35FD847Q41491985-3DB853B1-3166-495D-9470-649713490ABBQ42352636-6A2E2F2C-682E-4FC5-B8D4-E83C28FE84AAQ43691489-F1C75894-C6A2-45B7-933D-9C2AA0965C07Q45871757-CBB2B8DC-62BF-4E37-9F3F-F2AF75C69673Q50204340-F70B22ED-5F6E-484E-B89D-00B53B1219EF
P2860
Suppression of anti-cancer immunity by regulatory T cells: back to the future.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Suppression of anti-cancer immunity by regulatory T cells: back to the future.
@ast
Suppression of anti-cancer immunity by regulatory T cells: back to the future.
@en
type
label
Suppression of anti-cancer immunity by regulatory T cells: back to the future.
@ast
Suppression of anti-cancer immunity by regulatory T cells: back to the future.
@en
prefLabel
Suppression of anti-cancer immunity by regulatory T cells: back to the future.
@ast
Suppression of anti-cancer immunity by regulatory T cells: back to the future.
@en
P2093
P1476
Suppression of anti-cancer immunity by regulatory T cells: back to the future.
@en
P2093
Bryon D Johnson
M Eric Kohler
Rimas J Orentas
P304
P356
10.1016/J.SEMCANCER.2005.11.007
P577
2006-01-11T00:00:00Z